A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO
|
|||||
       |
 Comments are closed  Finance  biomedical, biotechnology, cancer, clinical trials, equity, FDA, investment, IPO, licensing, pharmaceuticals, venture capital 
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, FDA, genomics, health care, HIV, licensing, life sciences, pharmaceuticals, physical sciences, university 
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, contract, DoD, engineering, genomics, life sciences, manufacturing, mathematics, pharmaceuticals, physical sciences, U.K., university 
A clinical trial, testing stem cells for neurons fortified with tumor-killing viruses, administered its first doses to a patient with glioma, an aggressive type of brain cancer. . . . → Read More: Trial Underway Testing Engineered Cancer-Killing Viruses Comments are closed New products biomedical, biotechnology, cancer, clinical trials, grant, life sciences, NIH, pharmaceuticals, stem cells 
A biopharmaceutical company and university neuroscience lab are collaborating on a clinical trial testing a peptide nasal spray treatment for social anxiety disorder. . . . → Read More: Drug Maker, Univ. Lab Partner on Neuropeptide Anxiety Trial One comment - (Comments are closed) Joint ventures/collaborations biomedical, clinical trials, life sciences, pharmaceuticals, psychiatric, university 
Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years. . . . → Read More: Infographic – U.S. Life Science Venture Activity Keeps Falling Comments are closed Finance economics, entrepreneurs, equity, investment, life sciences, statistics, venture capital 
A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases. . . . → Read More: NIH Funding Single Home Test for Covid-19, Influenza, RSV Comments are closed Finance, New products biomedical, biotechnology, contract, Covid-19, engineering, genomics, life sciences, medical device, NIH, software 
A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field. . . . → Read More: Venture Fund to Back Life Science A.I. Start-Ups One comment - (Comments are closed) Finance biomedical, biotechnology, computer science, engineering, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, robotics, university, venture capital 
A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma. . . . → Read More: Trial Underway Testing Dried Plasma for Transfusions Comments are closed New products biomedical, clinical trials, engineering, licensing, life sciences, medical device, physical sciences 
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded Comments are closed Intellectual property agriculture, biotechnology, Canada, chemistry, engineering, life sciences, patent, physical sciences, USPTO |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts